MedTrace Logo

Effects of Therapeutic Mobile Game on Anxiety

NCT05240794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-10-05

No results posted yet for this study

Summary

Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on SAD symptoms, and metrics of functional impairment during this time. After the treatment period, participants will be followed at 6 month and 12 month after the completion of the study.

Conditions

Interventions

DEVICE

ABM-01

Gamified computerized behavioral therapy with therapeutic intervention based on Attention Bias Modification Training (ABMT)

DEVICE

Digital Control

Placebo control for ABM-01

Sponsors & Collaborators

  • Arcade Therapeutics Inc.

    collaborator UNKNOWN

  • Hunter College of City University of New York

    lead OTHER

Principal Investigators

  • Tracy A Dennis-Tiwary, PhD · City University of New York, School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2023-05-31
Completion
2023-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05240794 on ClinicalTrials.gov